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Glaucoma is a leading cause of blindness, affecting 70 million people worldwide. Owing to the similarity in anatomy and physiology
between human and mouse eyes and the ability to genetically manipulate mice, mouse models are an invaluable resource for
studying mechanisms underlying disease phenotypes and for developing therapeutic strategies. Here, we report the discovery of a
new mouse model of early-onset glaucoma that bears a transversion substitution c. G344T, which results in a missense mutation, p.
R115L in PITX2. The mutation causes an elevation in intraocular pressure (IOP) and progressive death of retinal ganglion cells (RGC).
These ocular phenotypes recapitulate features of pathologies observed in human glaucoma. Increased oxidative stress was evident
in the inner retina. We demonstrate that the mutant PITX2 protein was not capable of binding to Nuclear factor-like 2 (NRF2), which
regulates Pitx2 expression and nuclear localization, and to YAP1, which is necessary for co-initiation of transcription of downstream
targets. PITX2-mediated transcription of several antioxidant genes were also impaired. Treatment with N-Acetyl-L-cysteine exerted a
profound neuroprotective effect on glaucoma-associated neuropathies, presumably through inhibition of oxidative stress. Our
study demonstrates that a disruption of PITX2 leads to glaucoma optic pathogenesis and provides a novel early-onset glaucoma
model that will enable elucidation of mechanisms underlying the disease as well as to serve as a resource to test new therapeutic
strategies.
Cell Death and Disease         (2021) 12:1017 ; https://doi.org/10.1038/s41419-021-04331-1
INTRODUCTION
Glaucoma, affecting 70 million people worldwide, is a group of
neurodegenerative diseases characterized by the progressive
death of retinal ganglion cells (RGCs) and atrophic excavation of
the optic nerve, ultimately resulting in irreversible loss of vision
[1, 2]. Elevated intraocular pressure (IOP) is thought to be a major
risk factor for glaucoma, and patients with high-pressure
glaucoma generally present defects in outflow of aqueous humor
[3, 4]. IOP is maintained through a balance between aqueous
humor secretion, by the ciliary body (CB), and drainage through
the trabecular meshwork (TM), a porous tissue located in the
iridocorneal angle [5]. An increased resistance to aqueous humor
drainage can arise from developmental malformations of ocular
structures and ultimately lead to early-onset glaucoma.
Early-onset glaucoma cases generally have strong genetic
contributions and many disease-causing mutations that lead to
pathogenesis have been identified [6]. For example, mutations in
CYP1B1, LTBP2, MYOC, FOXC1, GPATCH3, and TEK have been
associated with Primary Congenital Glaucoma (PCG) [7]. Moreover,
mutations in PAX6, PITX2, PITX3, FOXC1, FOXE3, EYA1, LMX1B, and
MAF, have been detected in patients with early-onset secondary
glaucoma [8–12]. It should also be noted that glaucoma is a
complex, heterogeneous disease likely to be the consequence of
the interaction of multiple genes. This underlying complexity may
hinder efforts to identify glaucoma-associated genes (or related
mutations) and to uncover their pathogenic mechanisms.
Identification of monogenic murine glaucoma models, may assist
in addressing both of these issues. To this end, the Eye Mutant
Resource screening program at The Jackson Laboratory (JAX)
identified a glaucoma model caused by a mutation in Pitx2.
In humans, mutations in Paired-Like Homeodomain Transcrip-
tion Factor 2 (PITX2) has been associated with Axenfeld-Rieger
syndrome (ARS) (OMIM: 180500). PITX2, which encodes a member
of the bicoid-like class of homeodomain (HD) transcription factors,
play key roles in embryonic development and tissue morphogen-
esis. To date, a range of PITX2 mutations have been identified in
ARS patients including missense, nonsense, splicing mutations,
and copy number variations [13, 14]. The majority of ARS-causing
mutations are missense mutations within the HD region, which
may impair DNA binding and decreasing transactivation activity
[15]. ARS in humans is characterized by both systemic and ocular
anomalies, such as corneal opacity, iris hypoplasia, corectopia, and
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iridolenticular adhesions [12]. These developmental malforma-
tions of the anterior segment in ARS patients lead to severe forms
of early-onset glaucoma in ~50% of affected individuals.
Previous studies have suggested that Pitx2 deficiency in mice
lead to an arrest in anterior segment development in structures
derived from the periocular mesenchyme, including the cornea,
iris and outflow tract, which likely results from abnormal
differentiation and migration of neural crest cells during the
formation of anterior ocular structures [16–20]. Moreover, mice
heterozygous for a Pitx2 null allele recapitulate the anterior
segment dysplasia and developmental glaucoma observed in ARS
patients [21]. However, the role of PITX2 in maintenance of normal
optic function in adults and the precise mechanisms underlying
glaucomatous pathologies when PITX2 is disrupted remain largely
unknown.
In this study, we identified a novel missense mutation, c. G344T,
p. R115L, in Pitx2. In the homozygous state, mice bearing this
mutation presents with bulging and distended eyes, a striking
feature of glaucoma. Moreover, increased oxidative stress was
evident in mutant retinas, which further activated persistent glial
activation in the inner retina and RGC apoptosis. Mechanistically,
the missense mutation disrupts protein interaction of PITX2 with
NRF2 (regulating Pitx2 expression and nuclear localization) and
YAP1 (co-initiating transcription of downstream targets), leading
to impaired PITX2-mediated transcription of several antioxidant
genes, which activates the antioxidant response after ocular injury.
Additionally, treatment with N-Acetyl-L-cysteine exhibited pro-
found neuroprotective effect. Overall, this work describes a novel
early-onset glaucoma model and sheds light on the pathogenesis
of glaucoma in ARS.
MATERIALS AND METHODS
Mouse models
All animal experiments were approved by the Institutional Animal Care and
Use Committee of Sichuan Provincial People’s Hospital (Chengdu, Sichuan,
China) and The Jackson laboratory (JAX, Bar Harbor, Maine, USA) and
conducted in accordance with the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research.
The original mutant was identified in a N-ethyl-N-nitrosourea (ENU)
chemical mutagenesis screen in the Mouse Resource for Craniofacial
Research (http://craniofacial.jax.org/). Briefly, C57BL/6J male mice, G0, were
treated with ENU (weekly 80mg/kg dosage for 3 weeks), and bred to
normal C57BL/6J females after returning to fertility. G1 male offspring were
backcrossed to unmutagenized C57BL/6J females and their G2 female
offspring were backcrossed to their G1 sires to generate a population of G3
mice that were screened for visible phenotypes. A G3 mutant with a
shortened face and enlarged eyes was identified. This mutant was
backcrossed again to C57BL/6J and the short face phenotype segregated
from the ocular phenotype. This mutant was named early-onset glaucoma
(egl1) and was bred to homozygosity and subsequently maintained by
sibling intercrosses (C57BL/6J-Pitx2egl1/Boc; stock No. 004240). The egl1
mutant mice in this study were bred and maintained in standardized
conditions of the Research Animal Facilities at The Jackson Laboratory
(JAX). They were provided with a NIH31 6% fat chow diet and acidified
water, in a pathogen-free vivarium environment with a 14-hour light/10-
hour dark cycle.
Clinical evaluation and electroretinography
Eyes of all mice used in the characterization studies and linkage crosses
were dilated with 1% atropine ophthalmic drops (Bausch and Lomb
Pharmaceuticals Inc., Tampa, FL, USA) and were evaluated by indirect
ophthalmoscopy with a 78-diopter lens. Fundus photographs were taken
with a Micron III in vivo bright field retinal imaging microscope equipped
with image-guided OCT capabilities (Phoenix Laboratories, Inc, Phoenix,
AZ, USA). The intraocular pressure (IOP) was measured by an
induction–impact tonometer (TonoLab Colonial Medical Supply, London-
derry, NH, USA). IOP was measured immediately after induction with an
intraperitoneal injection of xylazine (80mg/kg) and ketamine (16 mg/kg) in
normal saline (~5min). The mouse was gently restrained by hand on an
adjustable platform, and the eye was oriented to align the probe tip with
the optical axis of the eye at about 2-mm distance under dissecting scope.
All tested animals with the same age were randomly divided into the
experimental groups. Five consecutive IOP readings were averaged.
For electroretinographic evaluation of mutants, following an overnight
dark adaptation, mice were anesthetized with an intraperitoneal injection
of xylazine (80mg/kg) and ketamine (16 mg/kg) in normal saline.
Additional anesthetic was given, if akinesia was inadequate. The
equipment and protocol used here have been previously described [22].
Briefly, dark-adapted, rod-mediated ERGs were recorded with the
responses to short-wavelength flashes over 4.0-log units to the maximum
intensity by a photopic stimulator. Cone-mediated ERGs were recorded
with white flashes after 10 min of complete light adaptation. The signals
were sampled at 0.8 ms intervals and averaged.
Whole-exome sequencing (WES)
DNA purification, library construction, deep Next Generation sequencing,
and data quality control was performed by the Jackson Laboratory’s
Genome Technologies service, and data analysis and annotation were
performed by the Computational Sciences Biostatistics service. Purified
genomic DNA from egl1/egl1 mice and C57BL/6J controls were used to
create libraries for whole-exome sequence (WES) capture. High-quality
reads were mapped to the mouse genome (GRCm38, mm10) and the
resulting alignment was sorted by coordinates and further converted to
binary alignment map (BAM) format by Picard v1.95 SortSam utility (http://
picard.sourceforge.net). Variants with total read depth >5X with the SNP
quality score >50 were included and variants in non-coding regions and
synonymous variants were excluded. The filtered candidate genes are
shown in Table S1.
Gene mapping, sequencing, and genotyping
To determine the chromosomal location of the egl1 mutation, we mated
egl1/egl1mice to DBA/2J mice. The resultant F1 mice, which did not exhibit
retinal abnormalities, were backcrossed to B6-egl1/egl1mice to produce N2
mice. Tail DNA was isolated as previously reported [23]. A genome-wide
scan of pooled DNA from 12 affected and 12 unaffected mice was carried
out using 48 microsatellite markers [24]. The egl1 phenotype cosegregated
with markers on Chromosome 3. Subsequently, DNAs of 93 N2 offspring
were genotyped using microsatellite markers to develop a fine structure
map of the Chromosome 3 region. Microsatellite markers D3Mit106 and
D3Mit291 were used to genotype individual DNA samples. The causative
mutation was identified by comparing the whole-exome sequences from a
homozygous egl1 mutant and control [25]. Between D3Mit106 and
D3Mit291 on Chromosome 3, a unique point mutation c.G344T of Pitx2
was identified in the filtered data of WES (Table S2), in egl1/egl1 but not in
wild-type DNA. Allele-specific PCR (AS-PCR) was used on genomic DNA to
confirm the presence of the Pitx2egl1 mutation. Three oligo primers were
selected from exon 2 of the Pitx2 gene with [G/T] single base change
(WT=G, egl1 mutant= T) using a web-based software “Web-based Alelle-
Specific Primer” (http://bioinfo.biotec.or.th/WASP): wild-type (W), mutant
(M) and common (C) primers: W reverse primer: CGAGTGGACATGTCTGGG-
TAAC; M reverse primer: CGAGTGGACATGTCTGGGTAAA; C forward primer:
AGCAAGGAAAGAATGAGGAT, and the PCR product size 145 bp (base pairs).
The AS-PCR assay was conducted in two parallel experiments: (1) “mutant
+ common” primer experiment (MC) and (2) “wild+ common” primer
experiment (WC). The PCR assay for Pitx2egl1 mutation was performed in
10 µl reactions. The PCR conditions were as followed: initial denaturation
for 3 min at 94 oC followed by 36 cycles of denaturation for 15 s at 94 °C,
annealing for 2 min at 55 °C, extension for 2 min at 72 °C, and a final
extension step for 7 min at 72 °C. PCR products were run on 1.5% SeaKem
agarose gel.
Generation of knock-in mouse model by CRISPR/Cas9
The CRISPR/Cas9 oligonucleotide directed approach was used to generate
the Pitx2 p.R115L knock-in (KI) mice. The gRNA (CTTCGCGAGTGGA-
CATGTCTGGG) designed to mouse Pitx2 gene together with Cas9 mRNA
and a donor oligo (CAGAGGACTCATTTCACTAGCCAGCAGCTGCAGGAGCTG-
GAAGCCACTTTCCAGAGAAACCTCTATCCAGACATGAGTACTCGCGAA-
GAAATCGCCGTGTGGACCAACCTTACCGAAGCCCGAGTCCGGGTAGGAGC-
CAGCACCCAATCTGGGAAAACGAGGGGGCCGAGGCC) containing the R115L
(CGC to CTC) mutation were co-injected into C57BL/6J mouse zygotes to
generate targeted knock-in offspring. F0 founder animals were mated to
C57BL/6J wildtype mice and subject to sequence analysis. Positive F1
offspring (Pitx2R115L, strain name C57BL/6J-Pitx2em1ZXJ, hereafter named
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Pitx2KI) were backcrossed to C57BL/6J for four generations and then
intercrossed to generate heterozygous and homozygous offspring. After
PCR amplification of the targeted region, homozygotes (Pitx2KI), hetero-
zygotes (Pitx2KI/+), and wild-type (Pitx2WT) could be determined by Sanger
sequencing analysis.
Genotyping of Pitx2KI mice
Genomic DNA was isolated either from tail tips or from blood using the
QIAamp DNA Blood kit (QIAGEN) according to the manufacturer’s
instructions. WES results or genotypes were confirmed by Sanger
sequencing with the following primers (Sangon Biotech, Shanghai, China):
Pitx2-Forward primer (F1): 5’-CGGTAGAGAGGTTGTAGATGGGAGTCT-3’;
Pitx2-Reverse primer (R1): 5’-GCAGAGAGCCGCTGAGGTTGTAG-3’. All PCR
amplification was performed using a master mix (Invitrogen, USA). The first
cycle consisted of 95 °C for 5 min, followed by 32 cycles of 95 °C for 15 s,
60 °C for 30 s and 72 °C for 30 s. The PCR products were purified by FastAP
Thermosensitive Alkaline Phosphatase (Thermo Scientific Fermentas), and
directly sequenced using BigDye version 3.1 and an ABI 3730 automated
sequencer (Applied Biosystems) according to the manufacturer’s
instructions.
Plasmids and site-directed mutagenesis
The recombinant expression plasmids, pcDNA3.1-PITX2-Flag, pcDNA3.1-
Nrf2-HA tag, and pcDNA3.1-YAP1-HA tag were purchased from Youbio Inc.
(Youbio, Changsha, China). Point mutation c. G344T was introduced into
the WT Pitx2 cDNA by site-directed mutagenesis using a QuikChange
Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara,
CA, USA) with a complementary pair of primers: F: 5’-CCACTTTCCAGA-
GAAACCTCTACCCAGACATG-3’ and R: 5’-CATGTCTGGGTAGAGGTTTCTCTG-
GAAAGTGG-3’. The recombinant plasmids containing PITX2 (R115L)-Flag
fusion constructs were sequenced to confirm the desired mutation and to
exclude any other sequence variations.
Cell culture and transfection
HEK293T and COS-7 cells were purchased from National Infrastructure of
cell line Resource (Wuhan, China) and were recently authenticated by STR
profiling. They were cultured in DMEM with high glucose (Hyclone, South
Logan, UT, USA) supplemented with 10% fetal bovine serum (Gibco, Grand
Island, NY, USA) and 100 U/ml penicillin/streptomycin (Invitrogen, Wal-
tham, MA, USA) in an incubator set to 37 °C with 5% CO2. For transfection,
cells were seeded in plates (Corning, NY, USA) and transiently transfected
with Flag-tagged PITX2WT/PITX2R115L or HA-tagged NRF2/YAP1 plasmid
using Lipofectamine 3000 (Invitrogen, CA, USA) according to the
manufacturer’s instructions, and the cell lysis were harvested after 48 h.
Immunocytochemistry
COS-7 cells were seeded in 24-well plates (Corning, Corning, NY, USA) and
transfected at 70% confluency with constructed vectors or empty vectors
using Lipofectamine 3000 (Invitrogen, CA, USA) according to the
manufacturer’s instructions. Cells were harvested after 48 h and fixed in
4% paraformaldehyde for 15min at room temperature. After blocking with
1× PBS containing 5% normal goat serum and 0.2% Triton X-100, cells were
incubated with specific antibodies at 4 °C overnight. The primary
antibodies used are shown in Table S3. AlexaFluor 594/488-conjugated
goat anti-mouse/rabbit secondary antibody (Cat# A11005 and A11008,
Invitrogen, Waltham, MA, USA, 1:500 dilution) was applied and nuclei were
counter-stained with DAPI (Cat# D8417, Sigma, St Louis, MO, USA).
Luciferase assay
The luciferase assays to detect the transcriptional activity of PITX2 were
performed as described previously [26, 27]. The human LEF-1 promoters
were constructed in the luciferase vector as previously described [28, 29].
SV-40 β-galactosidase reporter plasmid was used as a control for
transfection efficiency. 293T cells were prepared and mixed with 2.5 µg
of expression plasmids, 5 µg of reporter plasmid and 0.5 µg of SV-40
β-galactosidase plasmid in 60mm culture dishes. After incubating for 48 h,
transfected cells were lysed and assayed for reporter activities. Luciferase
activity was measured using reagents from Promega (Cat# E1500, Madison,
WI, USA). β-galactosidase was measured using Galacto-Plus reagents (Cat#
T2118, Invitrogen, Waltham, MA, USA). All luciferase activities were
normalized to β-galactosidase activity and are shown as mean-fold
differences relative to empty luciferase plasmids.
RNA-sequencing analysis
RNA-sequencing analysis was performed on four independent biological
replicates from four wild-type (WT) and four Pitx2 mutant retina at
2 months of age. After harvesting, both retinas for each animal were
collected and immediately frozen. RNA was extracted using RNeasy Mini
kits (QIAGEN). RNA integrity and concentration were evaluated using a
BioAnalyzer 2100 with RNA 6000 Nano Kit (Agilent Technologies, Santa
Clara, CA, USA). For library preparation, a total of 2 μg RNA per sample was
used as input material for the RNA sample preparations. Sequencing
libraries were generated using NEB Next, Ultra RNA Library Prep Kit for
Illumina® (Cat# E7530L, NEB, USA), following the manufacturer’s recom-
mendations, and index codes were added to attribute sequences to each
sample. Briefly, mRNA was purified from total RNA using poly-T oligo-
attached magnetic beads. Fragmentation was carried out using divalent
cations under elevated temperature conditions in NEBNext First-Strand
Synthesis Reaction Buffer (5×). First-strand cDNA was synthesized using
random hexamer primers and RNase H. Second-strand cDNA synthesis was
subsequently performed using dNTPs, DNA polymerase I and RNase H. The
library fragments were purified with QiaQuick PCR kits and eluted with EB
buffer, and then terminal repair, A-tailing and addition of an adapter were
implemented. The RNA concentration of the library was measured using a
Qubit RNA Assay Kit in Qubit 3.0 and the library was diluted to 1 ng/μl.
Insert sizes were assessed using the Agilent Bioanalyzer 2100 system
(Agilent Technologies), and the qualified insert size was accurately
quantified using a StepOnePlus™ Real-Time PCR System (library valid
concentration > 10 nM). The clustering of the index-coded samples was
performed on a cBot cluster generation system using a HiSeq PE Cluster Kit
v4-cBot-HS (Illumina, CA, USA) according to the manufacturer’s instruc-
tions. After cluster generation, the libraries were sequenced on an Illumina
HiSeq 2500 platform, and 150 bp paired-end reads were generated. All
gene expression values from RNA-seq were converted to a log2 value and
analyzed further. Then, a P value of less than or equal to 0.05 was
considered significant. The raw sequence data have been deposited in the
Genome Sequence Archive (Genomics, Proteomics & Bioinformatics 2021)
in National Genomics Data Center, Beijing Institute of Genomics, Chinese
Academy of Sciences, under accession number CRA005112 that are
publicly accessible at “https://ngdc.cncb.ac.cn/gsa”.
RNA extraction and quantitative PCR
Optic nerve total RNA was extracted using TRIzol reagent (Sigma, Saint
Louis, MO, USA) as recommended by the manufacturer. First-strand cDNA
was synthesized using iScript cDNA Synthesis Kit (Bio-Rad, Hercules,
California, USA). Quantitative PCR was carried out using iTaq SYBRMix (Bio-
Rad, Hercules, California, USA) and a CFX384 Touch Real-Time PCR
Detection System (Bio-Rad, Hercules, California, USA). Primers were
designed using Primer3Plus or from published resources. Table S4 shows
the specific primer sequences used. Four biological replicates were used
for each sample. All target genes were normalized to actin mRNA levels
and fold change were calculated by performing delta-delta Ct analysis [30].
Histological analysis
For haematoxylin and eosin staining (H&E), enucleated eyes from control
and mutant mice were fixed overnight in 1.22% glutaraldehyde and 0.8%
paraformaldehyde in 0.08 M phosphate buffer, embedded in paraffin and
then cut in 5 μm sections. To ensure sections used for quantification came
from the same eccentricity, the globe was embedded in the same
orientation. Sections that encompassed the optic nerve (ON) were selected
for staining with haematoxylin and eosin according to standard protocol.
Immunohistochemistry
For immunohistochemistry, eyes were removed from euthanized mice by
intraperitoneal injection of pentobarbital (75 mg/kg), and by cervical
dislocation and fixed in 4% paraformaldehyde in 100mM phosphate buffer
(pH 7.4) for 1 h at 4 °C, followed by cryoprotection in 30% sucrose for 2 h.
Lens were removed and eyes were embedded in optimal cutting
temperature solution (OCT) and sectioned at 10 μm thickness. After
blocking and permeabilization with 10% normal donkey serum and 0.2%
Triton X-100 in phosphate buffer for 1 h, the sections were labeled with the
primary antibody at 4 °C overnight. The primary antibodies used are shown
in Table S3. The sections were rinsed in PBS three times and Alexa Fluor
594/488-conjugated goat anti-mouse/rabbit secondary antibody (Cat#
A11005 and A11008, Invitrogen, Waltham, MA, USA, 1:500 dilution) was
applied and nuclei were counter-stained with DAPI (Cat# D8417, Sigma, St
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Louis, MO, USA) for 1 h at room temperature. Images were captured on a
Zeiss LSM 800 confocal scanning microscope. In addition, the expression
levels of CD68 and GFAP were compared between WT and mutant retinas
by quantifying their fluorescence intensities using ImageJ software.
Retinal flat mounts and RGC count
Retinas were dissected from enucleated eyes and flattened. Retinas were
immersed in 4% PFA for 24 h at 4 °C, then blocked in PBS containing 1%
bovine serum albumin and 0.5 % Triton X-100 and incubated with
polyclonal rabbit anti-Brn3a antibody (Cat#ab245230, Abcam, Cambridge,
USA, 1:200 dilution) for 12 h at 4 °C. After several washes, the retinas were
incubated with the secondary antibody, AlexaFluor 488-conjugated goat
anti-rabbit secondary antibody (Cat#A11008, Invitrogen, Waltham, MA,
USA, 1:250 dilution) for 4 h at room temperature, and subsequently
washed with PBS. To precisely quantitate the loss of RGCs, each retinal
quadrant was divided into four zones—nasal, temporal, superior, and
inferior—each located 1mm from the optic nerve head. RGCs were
counted in each unit area by two investigators in a blinded fashion, and
the scores were averaged.
Semithin-section processing of the optic nerve
Optic nerves were dissected from eyes and placed in a solution containing
4% paraformaldehyde and 0.2% glutaraldehyde for 24 h. After rinsing three
times in 0.1 M phosphate buffer (pH 7.4) for 15min each, tissues were fix
with 1% osmic acid and 0.1 M phosphate buffer (pH 7.4) at room
temperature (20 °C) for 2 h. Osmic acid fixed tissues were rinsed three
times in 0.1 M phosphate buffer (pH 7.4) for 15min each, and dehydrated
in graded concentrations of ethanol. The dehydrated tissues were
embedded in acetone: 812 embedding medium= 1:1 for 2–4 h, and in
acetone: 812 embedding medium= 1:2 infiltration, overnight, and finally
in 812 embedding medium for 5–8 h. Samples were inserted into an
embedding plate containing 812 embedding medium, and placed
overnight in an incubator at 37 °C, followed by polymerization at 60 °C
for 72 h. Semithin sections (1 μm) were cut transversely from segments of
optic nerves caudal to the eyeball and stained with 1% toluidine blue.
TUNEL assay
Apoptotic cell death was detected in prepared frozen sections by the
terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end
labeling (TUNEL) assay according to the manufacturer’s protocol
(Cat#11684795910, Roche Diagnostics, Indianapolis, IN). Images were
captured on a Zeiss LSM 800 confocal scanning microscope.
Immunoblotting
Samples for western analysis were lysed in standard RIPA lysis buffer
(50mM Tris-HCl, 150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycho-
late, 0.1% SDS, pH 7.4) supplemented with Complete Protease Inhibitor
Cocktail (Roche). The protein content of the samples were quantified by a
standard BCA method. SDS-PAGE was performed using standard
techniques. Blots were blocked with 8% non-fat dry milk in TBST for 2 h
at room temperature and subsequently incubated with primary antibodies
in blocking solution overnight at 4 °C. The primary antibodies used were
shown in Table S3. Primary antibodies were detected with either an anti-
mouse or anti-rabbit HRP-conjugated secondary antibody (1:5000; Bio-
Rad), and signals were developed using SuperSignal West Pico Chemilu-
minescent Substrate (Pierce). ImageJ was used to calculate the relative
density of the protein. At least three independent western blots were
conducted, and one representative blot is presented.
Coimmunoprecipitation and quantification
Transfected 293T cells were harvested and lysed in lysis buffer (50mM Tris-
HCl, pH 7.5, 150mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate
and 1% protease inhibitor cocktails; Sigma, St. Louis, MO, USA) and
incubated on ice for 5 min with periodic agitation. Cell lysates were
centrifuged, and the supernatant was incubated with antibodies of interest
and Protein G Plus/Protein A agarose beads (Sigma, St. Louis, MO, USA) or
Flag M2-conjugated agarose beads (Sigma, St. Louis, MO, USA) at 4 °C
overnight. The beads were washed six times with cell lysis buffer, and the
precipitated proteins were further analyzed by western analysis.
To quantify the interaction between WT/mutant PITX2 and NRF2/ YAP1,
ImageJ was used to calculate the intensity of the targeted protein. The
intensity of IP bands/ input bands was calculated to normalize the total
protein content. The relative binding capacity was quantified by the
normalized IP-HA intensity/normalized IP-Flag intensity. At least three
independent co-IP experiments were conducted, and one typical blot is
presented.
Measurement of superoxide production
Superoxide production was evaluated in retinal cryosections using
dihydroethidium (DHE) as described previously [31]. Briefly, frozen sections
were incubated with DHE (2 μM) for 30min at 37 °C. DHE is oxidized upon
reaction with superoxide to ethidium bromide, which binds to DNA in the
nucleus and fluoresces red. Excessive reactive oxygen species (ROS)
production is a hallmark of oxidative stress. Thus, retinal levels of
superoxide, as determined by DHE staining with subsequent quantification
of fluorescence intensity, was measured. Images were captured on a Zeiss
LSM 800 confocal scanning microscope. The relative fluorescence intensity
within the images obtained was determined via automated image analysis
of ZEISS ZEN Intellesis or ImageJ software.
Measurement of the MDA level and SOD, GSH-Px activity
Retinas were immediately extracted from enucleated eyes. The weighed
retinal samples were prepared as a 10% homogenate in 0.9% saline. After
homogenization on ice, the homogenate was sedimented at 2000 × g for
10min, and the supernatant was collected and diluted. The GSH-Px, SOD
activity, and MDA levels of the retinal lysates were determined using ELISA
kits from the Nanjing Jiancheng Bio-company (Cat#A005, A001, A003,
respectively, Nanjing, China). All procedures were carried out according to
the manufacturer’s instructions.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 6 software. The
data sets were tested for normal distribution using Shapiro–Wilk test. For
normally distributed data, statistical significance was determined by
Student’s t-test or ANOVA. If the data was not normally distributed, non-
parametric statistic was used. p-values were calculated by Student’s t-test
or ANOVA followed by a, Tukey, Dunnett or Sidak’s multiple comparisons
test as appropriate. P < 0.05 was considered statistically significant.
RESULTS
A new model of early-onset glaucoma identified in an ENU
screening program
The egl1 mutant, with bulging eyes, was discovered while
screening an ENU treated cohort for craniofacial phenotypes.
Affected mice were distinguished from C57BL/6J controls by a
high IOP phenotype (Fig. 1A). Optic neuropathy characterized by
optic nerve cupping, and by severe retinal nerve fiber layer (NFL)
loss in mutant retinas (Fig. 1B) was detected with optical
coherence tomography. Histological study of retinas from 12-
month-old mice confirmed the clinical assessment, and revealed
enlarged optic disc cup with thinning of the inner retinal layer in
mutant mice (Fig. 1C). Whole-exome sequences (WES) revealed a
G to T base-pair transversion in Pitx2 (Fig. 2A–D). Allele-specific
PCR (Fig. S1) and Sanger sequencing (Fig. S2) further confirmed
the presence of Pitx2egl1 mutation in a segregating cross. Thus, a
novel homozygous missense mutation, c. G344T, p. R115L
(NM_001042502.2), in the Pitx2 gene was identified and deemed
the most likely candidate for the glaucoma-like symptom in egl1/
egl1 mice. Notably, the affected amino acid residue is located in
the HD region of PITX2 protein (Fig. 2D, lower panel) and is highly
conserved across species (Fig. 2E).
Generation of the Pitx2Mut mouse model
In order to confirm the causative nature of the egl1 mutation and
explore the Pitx2 mutation further, a Pitx2R115L knock-in mouse
model (named KI) was generated using CRISPR/Cas9 technology
(Fig. S3). Homozygous Pitx2KI mice were born at the expected
Mendelian ratio (47 out of 220 in Pitx2KI/+ to Pitx2KI/+ crosses) and
was not significantly different from the expected, 55 out of 220
mice. No significant changes in the protein content and
localization pattern of PITX2 were observed in mutant retina
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compared to that of control (Fig. S3C, D). Immunofluorescent
staining of sections from WT mice indicated that PITX2 was
strongly expressed in the mouse GCL, where it colocalized with
the RGC marker, Brn3a (Fig. S3D, upper panel), suggesting that
PITX2 may play a role in RGC function.
Pitx2KI mice develop elevated IOP subsequent to anterior
segment dysgenesis
Similar to the Pitx2egl1 mutant mice, we observed that approxi-
mately 59% of mutants (20 out of 34) exhibited a bulging and
distended appearance of the eye with a mild corneal opacity
(Fig. 3A), as early as 2 months of age. Moreover that roughly 80%
of these cases were bilaterally affected, as reported for ARS
patients [19]. Rebound tonometry confirmed elevated IOPs in
mutants. As expected, Pitx2KI mice exhibited a progressive
elevation of IOP measurements, 13.87 ± 0.89 mmHg (n= 16),
16.38 ± 1.13 mmHg (n= 16), and 18.78 ± 1.54 mmHg (n= 18) at
3, 6 weeks, and 4 months of age, respectively. In contrast, the IOP
measuring of their control littermates at corresponding ages were
11.16 ± 1.58 mmHg (n= 16), 13.17 ± 1.88 mmHg (n= 16), and
14.62 ± 2.34 mmHg (n= 18) (Fig. 3B), which is consistent with
previous measurements for C57BL/6Jstrains [32]. By 4-months of
age, 47% of mutants presented with high IOP levels of >18 mmHg,
and ~14% mutants with IOP > 21mmHg, a level commonly
associated with glaucoma (Fig. 3C). Interestingly, nearly 53% of
mutants did not develop ocular hypertension at this stage
indicating incomplete penetrance of the disease. Similarly, only
50% of ARS patients develop elevated IOP and glaucomatous
pathologies [33–35].
Previous studies have demonstrated that PITX2 is required for
normal ocular development [21, 36]. We, therefore, sought to
determine whether the elevated IOP in Pixt2KI mice was associated
with aberrant ocular development. Mice were examined at E15.5,
P9 and 6 weeks for morphological alterations by histology. The
anterior chamber of mutant mice at E15.5 appeared slightly
collapsed and showed delayed separation of the cornea from the
lens surface compared to Pitx2WT mice, but otherwise no other
suggestion of abnormal development was apparent (Fig. 3D,
upper panel). By contrast at P9, multiple malformations of the
anterior chamber were observed in mutant eyes. A distinct
disruption of the iridocorneal angle with adhesion of the iris to
cornea, creating a fully angle closure was observed in mutant eyes
(Fig. 3D, middle panel). The iris-cornea adhesion was more
pronounced in adults, at 7 weeks of age, and was accompanied
by iris hypoplasia and ciliary body atrophy in all mutant eyes (Fig.
3D, lower panel).
Moreover, histological analysis in 7-week-old Pitx2 mutant mice
revealed a thinner cornea compared to that of control, with a
reduced thickness of both the epithelial and stromal layers (Fig.
3D). Detailed longitudinal analysis of the mutant and WT mice
from P16, 6-week- to 3-month-of age confirmed the reduced
central corneal thickness (Fig. 3E, F), suggesting an abnormal
corneal development. In addition, the TM and Schlemm’s canal
(SC) in 1-month-old mutants were occluded and not readily
identifiable, and the trabecular endothelial cells were tapered and
attenuated without regular cellular components (Fig. 3G, upper
panel). To further examine the TM malformation, ocular frozen
sections were stained for α-SMA, a marker for TM cells. This
analysis revealed that the majority of mutants exhibited an
absence or smaller area of α-SMA staining compare with that of
control, corroborating the TM hypoplasia in Pitx2KI mice (Fig. 3G,
H). It should be noted that all heterozygotes (Pitx2KI/+) tested at
3 months of age were not significantly different in ocular
morphology or in IOP levels compared to their WT littermates
(Fig. S4A, B), and all retinal structures, including the optic nerve
head and anterior segment appeared normal (Fig. S4B, C).
Fig. 1 Pitx2egl1 mice exhibit an early-onset glaucoma phenotype. A Longitudinal intraocular pressure analysis of Pitx2WT and Pitx2egl1 mice
(n= 12 for each group). Intraocular pressure (IOP) measurements with a rebound tonometer (TonoLab) showed a progressive increase in
pressure in Pitx2egl1 mutant mice. IOP (gray bar, egl1mice= 22.1 ± 3.4 and black bar, WTmice= 17.4 ± 2.2) at 1 month of age. IOP (gray bar, egl1
mice= 28.6 ± 5.0 and black bar, WTmice= 18.0 ± 1.7) at 2 months of age. IOP (gray bar, egl1mice= 30.6 ± 6.5 and black bar, WTmice= 16.3 ±
1.3) at 6 months of age. IOP (gray bar, egl1mice= 23.1 ± 1.4 and black bar, WTmice = 18.4 ± 1.7) at 12 months of age. B Representative fundus
photographs and optical coherence tomography images of Pitx2WT and Pitx2egl1 mice at different ages. A partial ring around optic cup in the
fundus and and optic nerve cupping observed by OCT in Pitx2egl1 mice (bottom row), but not in Pitx2WT mice (upper rows) at 2, 6, and
12 months of age. The green lines indicate the plane in which the B-scan to the left of the fundus images were taken C Representative images
of histologic sections taken through nerve heads from Pitx2WT and Pitx2egl1 mice at 12 months of age. Optic nerve head cupping was observed
in Pitx2egl1 mice, with thinning of inner retina layers. Scale bar: 200 μm. **P < 0.01; ***P < 0.001. Data are presented as the mean ± SEM.
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Retinal ganglion cell loss and optic nerve degeneration in
Pitx2KI mice
To determine whether high IOP leads to optic neuropathy in
Pitx2KI eyes, we assessed retinal and optic nerve morphology in
histological sections ON. Eyes of P16 mutant mice, an age prior
to IOP elevation, exhibited a normal retinal layer morphology
(Fig. S5A). At 6 weeks, a mild loss of cells in the ganglion cell layer
(GCL) was observed in mutant mice (Fig. S5B), and this trend
generally progressed with age.
At 3 months, mutant mice showed a mild thinning of outer and
inner nuclear layers (Fig. S6A, B), accompanied by a 61.2%
decrease in GCL cell number compared to that of controls
Fig. 2 Identification of Pitx2 mutation in Pitx2egl1 mice by whole-exome sequencing. A Genetic and molecular analysis of the egl1 strain. A
total of 93 progeny from a egl1/egl1 X (egl1/DBA/2J) F1 backcross were genotyped in a genome-wide scan. Linkage to several markers on
mouse Chr 3 was observed. The columns of squares represent haplotypes (filled boxes, egl1/egl1 B6 alleles; open boxes, egl1B6/DBA/2J allele).
The number of chromosomes associated with each haplotype is indicated below each column. B Genetic map of Chr 3 in the egl1 region
showing the closest markers and the region of human homology. C Integrative Genomics Viewer (IGV) shows the base substitution. D A
homozygous missense mutation, c. G344T, p. R115L of the Pitx2 gene was identified in Pitx2egl1 mice by whole-exome sequencing (WES).
Upper panel: The schematic diagram shows the location of the missense mutation in the Pitx2 gene. Bottom panel: Functional domains of
PITX2 protein with the location of the mutations. HD, homeodomain; OAR, opt aristaless and rax. E Protein sequence alignment of amino
sequences surrounding the Pitx2 mutation with orthologous sequences from Mus musculus to Xenopus tropicalis. The mutant amino acid
residue is in red. Note that the amino acid sequences surrounding the affected amino acid residues are also highly conserved.
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(Fig. S6A, C), indicating significant RGC loss. This result was
precisely confirmed with anti-Brn3a, an RGC-specific marker,
stained retinal section from 6-week-old (Fig. 4A) and 3-month-
old (Fig. 4B) mice, which demonstrated a progressive RGC death in
mutants (Fig. 4C). RGC density was further examined with anti-
Brn3a stained retinal flatmounts from 3-month-old animals. Each
anti-Brn3a stained retinal flatmount was segmented into nasal,
temporal, ventral, and dorsal quadrants, and RGC density
Fig. 3 Elevated intraocular pressure and hypoplasia of ocular anterior segment in Pitx2KI mice. A Image of Pitx2WT and Pitx2KI adult mice at
4 months of age. B Intraocular pressure analysis in the Pitx2WT and Pitx2KI mice at 3 weeks (n= 16), 6 weeks (n= 16) and 4 months (n= 18) of
age. Individual IOP values were shown as dots in the histogram. C Histogram showing the proportion of eyes in each IOP range at 4 months. D
Hematoxylin and eosin (H&E) staining of eyes of Pitx2WT and Pitx2KI mice at E15.5, P9, and 7 weeks. Compared with Pitx2WT mice, anterior-
segment development in E15.5 Pitx2KI mice was slightly impaired. Scale bars: 100 μm. Iris-cornea adhesion and closed iridocorneal angle (red
arrows) were detected in mutant mice at P9 and 7 weeks of age. Scale bars: 200 μm. The bottom panels show high-magnification images of
the boxed areas, which denotes a thinner corneal epithelium in PitxKI mice at 7 weeks. Scale bars: 50 μm. CB, ciliary body; CEn, corneal
endothelium; CEp, corneal epithelium; CS, corneal stroma. E H&E-stained sagittal sections of E15.5, P9, and 7 weeks old WT littermates and
mutant samples. Scale bars: 200 μm. F A comparison of central corneal thickness between mutants and their WT littermates (n= 6 in each
group). Mutant mice present a thinner central cornea relative to their WT littermates. Individual thickness values are shown by dots in the
histograms. *P < 0.05; ***P < 0.001. Data are presented as mean ± SEM. G Position-matched images of the H&E staining (upper panel) and the
immunofluorescent staining (lower panel) of optic sagittal sections are shown. Trabecular meshwork (TM) is labeled with alpha-smooth
muscle actin (α-SMA), and nuclei counter-stained with DAPI. Conventional outflow tissues are outlined by white boxes. Asterisks indicate
Schlemm’s canal (SC) lumen, arrowheads show trabecular meshwork. Scale bars: 25 μm. H Data show the percentage of α-SMA staining
measurements in the boxed TM region. Staining was assessed by ratings of “robust”, “mild”, or “absent”. (n= 6 in each group). *P < 0.05; ***P <
0.001. Data are presented as mean ± SEM.
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quantified respectively. In mutant retinas, a significant decrease in
Brn3a-positive cells in all four quadrants was observed (Fig. 4D).
Quantitative analysis revealed a 43.4 %; 32.8%; 24.3%, and 27.5%
reduction of Brn3a-positive cells compare to that of WT in nasal,
temporal, ventral, and dorsal area, respectively (Fig. 4E).
We next evaluated optic disc cupping, a characteristic
pathology of glaucoma. Clinical fundus examination revealed a
glaucomatous fundus appearance with an asymmetric and
severely excavated ON head and peripapillary chorioretinal
atrophy in mutant eyes (Fig. 4F). Consistent with clinical fundus
examinations, histological analysis revealed optic disc cupping
and thinning of the NFL near the ON in mutant mice at 7 weeks of
age, and these phenotypes became more severe at 3 months (Fig.
4G, H). Moreover, severe axon loss was also visible in the central
retina of mutant mice, as evidenced by an extremely atrophied
NFL, which was confirmed by Neurofilament-L staining (Fig. 4I). To
determine details of axonopathy, toluidine blue-stained semithin
sections of the ON from 3-month-old animals were prepared and
the number of axons were quantified. Compared with WT mice,
the axons density was clearly lower in mutant mice and was
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accompanied by axonal swelling and extensive myelin debris
(Fig. 4J, K), indicating severe axonal damage. Additionally, to
assess if pathological changes in mutants with normal IOPs
(≤18) occurred, we also examined these mutants. Interestingly,
pathologic features of glaucomatous injuries, such as RGC loss
(Fig. S7A, B) and ON damage (Fig. S7C–E). were observed but
the phenotypes appeared milder compared to mutants with
elevated IOPs.
Vision loss after ON degeneration is also a hallmark of glaucoma.
We thus tested vision function of 3-month-old mice using ERG
recordings. The scotopic b-wave amplitude was reduced at 0.3, 3,
and 20 cd sec/m2 flash intensities (Fig. S8A–C, G), and the photopic
b-wave (Fig. S8D, E, H) and flicker amplitude (Fig. S8F, I) was also
reduced in mutant mice, while no difference was observed for the
scotopic a-wave amplitude (Fig. S8A–C, G), suggesting impaired
visual function in the inner retina. Additionally, the amplitudes of the
oscillatory potentials (OPs), which originate from the functional inner
retina in mice [37], were also significantly reduced in mutant mice
(Fig. S9), reflecting inner retinal dysfunction.
Biochemical analysis of mutant PITX2 proteins
RT-PCR was performed on mRNA extracted from retina of adult WT
mice. Among the three alternatively-spliced murine isoforms
(Pitx2a, Pitx2b and Pitx2c) (Fig. S10A), RT-PCR analysis revealed that
only Pitx2c isoform was expressed in the mouse retina (Fig. S10B).
c. G344T variant was introduced into Pitx2c coding sequence by
site-directed mutagenesis to examine the impact of this variant.
Western analysis showed unique immune positive bands when
probed with anti-PITX2 antibody or Flag-tag antibody (Fig. 5A),
suggesting unchanged expression level (Fig. 5B). Immunofluores-
cence staining revealed that both WT and mutant proteins mainly
localized in the nucleus (Fig. 5C). These data demonstrated that
this variant is unlikely to impact the expression and cellular
localization of the PITX2 protein.
The missense mutation disrupts the interaction of PITX2 with
NRF2/YAP1 and impairs the transcriptional activity of PITX2
for antioxidant genes
Previous studies suggest PITX2 expression and activity depends on
NRF2-activated transcription and nuclear shuttling, where PITX2
binds to YAP1 and cooperatively activates transcription of
antioxidant genes in mouse myocardium after injury [38]. We
reasoned that the interactions of PITX2 with NRF2/YAP1 could also
play key roles in the transcription of antioxidant genes under
injury condition in the retina. Thus, we analyzed the interactions
between WT or mutant PITX2 and NRF2/YAP1 by coimmunopreci-
pitation, in transiently transfected 293T cells. Upon co-expression of
Flag-tagged WT PITX2 and HA-tagged NRF2, a distinct anti-HA signal
(NRF2) was detected in cell lysates as well as Flag precipitates (Fig.
5D, left panel), confirming that PITX2 interacts with NRF2. We
similarly confirmed interactions of PITX2 with YAP1 (Fig. 5D, right
panel). By contrast, in the presence of mutant PITX2, the anti-HA
signal (NRF2) was significantly weakened in Flag precipitates using
the same procedure (Fig. 5E, left panel), and that of YAP1 was almost
undetectable (Fig. 5E, right panel). Relative quantification (detail in
methods) indicated that the binding capacity of mutant PITX2 to
NRF2 and YAP1 was reduced 53.78% and 89.12% of WT PITX2,
respectively (Fig. 6C), indicating that the missense mutation disrupts
the interaction of PITX2 with NRF2 and YAP1, which might in turn
affect its transcriptional activity. We then evaluated the transcrip-
tional activity of the mutant PITX2 by assessing luciferase activity in
transfected 293T cells using the LF-2700 promoter constructs [29].
Compared with the empty vector, WT PITX2 activated transcription
from the LF-2700 promoter construct by approximately 12-fold (Fig.
5G). By contrast, the mutant PITX2 lost ~69.7% of its transcriptional
activity compared to WT version (Fig. 5G). Thus, the missense
mutation impairs the ability of PITX2 protein to recognize and bind
to its target sequences and activate transcription of downstream
genes. Additionally, to further determine whether the NRF2-YAP1
axis participates in anterior chamber failure in Pitx2KI animals, ocular
cryosections were immunofluorescently labeled using antibodies
against NRF2 and YAP1. No significant difference in staining was
observed between WT and mutant mice (Fig. S11), implying
that other mechanisms may underly the anterior chamber
malformations.
We next performed transcriptomic analysis using of retinas from
2-month-old Pitx2 mutant mice and WT littermate controls to
obtain insights into the molecular mechanisms. Analyses of the
RNA-seq data revealed that expression of the antioxidative
response-related genes (Cyp2a5, Upk3b1, Rrm2, Cyp26a1, Plet1,
Slc25a24, Cyp2s1, Cyp2f2, Cyp26b1, and Cyp4a12b) were signifi-
cantly downregulated in Pitx2 mutant retinas (Fig. 5H). These
results were further confirmed by real-time quantitative PCR
(qPCR) (Fig. 5I). Taken together, based on the transcriptome
results, we propose that the rapid RGC loss and ON dystrophy in
mutant retina results not only from the elevated IOP caused by
anterior segment dysgenesis, but also to the compromised
antioxidant capacity caused by impaired PITX2 transcriptional
activity of antioxidant genes.
Pitx2KI mutant retinas exhibit increased oxidative stress
Given the impaired PITX2-mediated transcription of antioxidant
genes in mutant mice, we next examined the oxidative status of
Pitx2KI retinas of 6-week-old mice. Several indicators of oxidative
stress were evaluated by ELISA using isolated retinal lysates.
Compared to controls, decreased activities of the antioxidant
Fig. 4 Ganglion cell loss and optic nerve atrophy in Pitx2KI mutant mice. A, B Retinal RGCs from 6-week-old (A) and 3-month-old (B) mice
were labeled with anti-Brn3a, and the nuclei were counter-stained with DAPI. Scale bars: 25 μm. C Quantification of the Brn3a+ RGC number in
GCL. Pitx2KI mutant mice at 3 months of age exhibit slightly thinner inner and outer nuclear layers compared with WT mice (n= 6 per cohort).
D Representative immunofluorescent enface images of enface view of a retinal flatmount from WT and mutants at 3 months of age labeled
with anti-Brn3a for detecting RGCs. Scale bars: 50 μm. E Pitx2KI mutants have significantly decreased numbers of RGCs per mm2 (n= 8) relative
to their control littermates (n= 10). F Fundus photograph at 5 months shows abnormal morphology of optic nerve head (arrowhead) in the
eyes of Pitx2KI mutant mice. G Representative images of histologic sections taken through nerve heads from Pitx2WT and Pitx2KI mice at 7 weeks
and 3 months of age. The optic nerve head appeared abnormal in Pitx2KI mice at both ages, with thinning of the nerve fiber layer (NFL) (red
arrowheads) and optic nerve excavation is noted (asterisk). Black arrows indicate NFL entering the optic nerve (ON); V: Central blood vessel.
Scale bars: 200 μm. H Quantitation and comparison of the NFL thickness near the optic nerve in 7-week and 3-month-old mice (n= 6 per
cohort). I Position-matched images of the H&E staining (upper panel) and the immunofluorescent staining (lower panel) of retinal cross
sections are shown. Retinal nerve fibers were labeled with neurofilament-L (NF-L), and the nuclei were counter-stained with DAPI. Scale bars:
25 μm. J Optic nerve atrophy was assessed in cross semithin sections of resin-embedded optic nerves from 5-month-old WT and mutant mice
stained with toluidine blue staining. Scale bars: 100 μm. The panels on the right show high-magnification images of the boxed areas shown in
the panels on the left. Scale bars: 10 μm. K Quantification of axon number in the optic nerve of 5-month-old mice (n= 10 per cohort). The
Pitx2KI mutants have significantly less axonal projections compared to Pitx2WT mice. ONL, outer nuclear layer; INL, inner nuclear layer; GCL,
ganglion cell layer. The statistics were calculated based on data from all tested mutants. The representative images of Pitx2KI were from
mutants with elevated IOPs. **P < 0.01; ***P < 0.001. #, no significant difference. The data are presented as mean ± SEM.
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enzymes superoxide dismutase (SOD) and glutathione peroxidase
(GSH-Px) and increased malondialdehyde (MDA) content were
observed in mutant retinas (Fig. 6A–C), suggesting compromised
antioxidant capacity and peroxidation in mutant retinas.
Retinal cryosections stained with dihydroethidium (DHE)
(Fig. 6D) showed increased DHE reaction in n mutant retinas.
Quantification of fluorescence intensity revealed a significant
increase in superoxide production in mutant mice, compared to
Fig. 5 Analysis of the biochemical and molecular changes observed in Pitx2KI mutant mice. A Expression of WT and mutant PITX2 proteins
in 293T cells. The pCMV-Pitx2WT and pCMV-Pitx2R115L expression plasmids were transfected into 293T cells. Western blot analysis showed
mutant PITX2 protein had the same abundance as WT. Antibody of Flag-tag was used to verify the specificity of PITX2 antibody. β-actin was
used as the loading control. B Quantitative comparison of the WT and mutant PITX2 protein levels in transfected cells (n= 6 per cohort). C
Subcellular localization of WT and mutant PITX2 proteins in COS7 cells. Immunocytochemistry study using anti-PITX2 antibody indicated that
both WT and mutant PITX2 proteins were localized in the nucleus. D 293T cells were co-transfected with the indicated constructs. Flag
immunoprecipitation, and blotting with anti-HA confirmed physical interaction. PITXWT-Flag was immunoprecipitated and the amount of co-
precipitated NRF2-HA (left panels) or YAP1-HA (right panels) was determined by immunoblotting, shown are representative immunoblots. E
PITX2R115L-Flag was immunoprecipitated and the amount of co-precipitated NRF2-HA (left panels) or YAP1-HA (right panels) was determined
by immunoblotting, shown are representative immunoblots. F Quantification of immunoblots reveals the PITX2 p. R115L mutation decreases
its interaction with NRF2 and YAP1 compared to WT (n= 4 in each group). G The transcriptional activity of WT and mutant PITX2 was detected
with a luciferase reporter in transient transfections of 293T cells. All luciferase activities are normalized to β-galactosidase activity and shown
as mean-fold activation compared with the vector. Five independent replicas were performed. The mean LEF-1 promoter luciferase activity
with PITX2 expression was about 200,000 light units per 15 μg protein, and the β-galactosidase activity was about 65,000 light units per 15 μg
protein. H RNA-seq results showing that several antioxidant-related genes are downregulated in mutant retinas. I RT-qPCR verified the
RNA-seq results for the indicated genes (n= 12). *P < 0.05; **P < 0.01; ***P < 0.001. #, no significant difference. The data are represented as
mean ± SEM.
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that of controls (Fig. 6E). In addition, both immunofluorescence
and western blot demonstrated a significant increase in the NRF2
level in mutant retinas compared to controls (Fig. 6F–H). NRF2
regulates the expression of antioxidant proteins that attenuate
cellular oxidative stress, thus its increased expression signifies
activation of oxidative stress.
Glial activation and RGC apoptosis in Pitx2KI retinas
We assessed the status of glial activation in mutant retinas from 2-
month-old mice. In control retinas, CD68 immunoreactivity was
weak and punctate, while in mutant retinas staining was intense
and agminated in the inner retina (Fig. S12A), suggestive of an
activated state. Moreover, the expression level of another
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microglia marker Iba1 was found to be increased in mutant retinas
by western blot analysis (Fig. S12B, C). Additionally, activated
Müller glia were also distinctly recognizable in mutant retinas by
immunostaining with an antibody against glial fibrillary acidic
protein (GFAP) (Fig. S12A). These data confirmed astrogliosis in
mutant retinas characterized by upregulation of GFAP level
relative to controls (Fig. S12B, C). TUNEL assay revealed increased
cell apoptosis in the GCL of mutant retinas, likely due to
prolonged oxidative stress and excessive inflammatory reaction
(Fig. S12D, E).
Treatment with N-Acetyl-L-cysteine mitigates high intraocular
pressure-induced retinal injury by inhibiting oxidative stress
in Pitx2KI retinas
The apparent oxidative stress and subsequent ocular injury
prompted us to investigate whether an oxidative reductant would
have protective efficacy in Pitx2 mutant mice. N-Acetyl-L-cysteine,
an antioxidant, provides increased glutathione and exerts
antioxidative protection. Thus, to rescue the RGC degeneration,
N-Acetyl-L-cysteine (25 mg/kg/day) or PBS (serve as vehicle
control), were intraperitoneally administered daily to Pitx2 WT or
mutant mice after 5-weeks of age (Fig. 7A). After 5 weeks of
treatment, mice were sacrificed to analysis.
N-Acetyl-L-cysteine-treated mutant mice (hereafter treated)
showed no significant differences in IOP from vehicle-treated
mutant mice (hereafter vehicle) (Fig. 7B). However, ROS activity
was significantly affected in retinas of treated mutant mice.
Imaging of vehicle mutant retinas demonstrated an increased DHE
reaction in the GCL, INL, and ONL (Fig. 7C), while the DHE-
superoxide reaction was largely prevented in the treated mutant
retinas, which showed comparable staining intensity to that in WT
retina (Fig. 7D). N-Acetyl-L-cysteine administration likely improved
the oxidative stress response induced by elevated IOP in mutant
retinas.
The RGC loss and ON damage was also evaluated by histological
analysis. In vehicle mutant mice, the number of cells in GCL was
drastically decreased compared to vehicle-treated WT controls. By
contrast, the number of cells retained in the GCL were significantly
greater in mutant mice administered N-Acetyl-L-cysteine, com-
pared with corresponding vehicle-treated mice (Fig. 7E, F). The
RGC density was further evaluated by immunofluorescent staining
of Brn3a of retinal flatmounts. Consistent with H&E staining, N-
Acetyl-L-cysteine treatment appeared to increas the number of
Brn3a-positive cells in mutant retina compared to that of vehicle
mutant mice in all four retinal quadrants (Fig. 7G), but still did not
reach WT levels (Fig. 7H). To directly monitor the therapeutic effect
on RGC death, the RGC number between vehicle- and treated-
group of each genotype (indicated as Δ RGC number) were
quantified. An increased number of Brn3a-positive cells after N-
Acetyl-L-cysteine treatment was observed (Fig. 7I). Together, these
data suggested that N-Acetyl-L-cysteine displays significant
therapeutic effect on glaucomatous neuropathies through mitiga-
tion of oxidative stress and subsequent partial preservation of RGC
in Pitx2KI retinas (Fig. 8).
DISCUSSION
The anatomical and physiological similarity between human and
mouse eyes and the ability to genetically manipulate mice make
them an excellent model to investigate disease mechanisms and
potential intervention of diseases, such as glaucoma. The heritable
DBA/2J glaucoma model has provided invaluable information on
disease cell biology and intervention [39–41]. However, elevated
IOP and glaucoma phenotypes do not manifest until 9–12 months,
making mechanistic studies and testing of therapeutic strategies
expensive and time-consuming. As a novel ENU induced Pitx2egl1
and the CRISPR/Cas9 mediated Pitx2KI glaucoma models exhibit
early-onset glaucoma, including elevated IOP and RGC degen-
erative phenotypes., they provide valuable insight into degenera-
tion of RGC and its related molecular pathways. At the molecular
level, the PITX2 p.R115L missense mutation disrupts binding of
PITX2 to YAP1 and NRF2 and impairs its transcriptional activation
of downstream genes involved in regulating oxidative stress
(Figs. 5 and 6). Reduced activities of the antioxidant enzymes SOD
and GSH-Px were observed in Pitx2 mutant retinas, indicating
compromised antioxidant capacity and peroxidation (Fig. 5). In
support of this, treatment with N-Acetyl-l-cysteine mitigates the
RGC injury observed, presumably by inhibiting oxidative stress in
mutant retinas (Fig. 7).
Alterations in the level of functional PITX2 protein (either
increased or decreased) may contribute to the pathologies
observed [42]. Previous studies reported that heterozygote Pitx2
null mice exhibited thinning of the ventral body, small body size,
and ocular and tooth defects [21], whereas in other studies
heterozygote alleles do not show obvious haploinsufficient
phenotypes [43]. In the present study, heterozygous Pitx2KI
mutants do not show any obvious glaucomatous phenotype
(Fig. S3). This is probably due to the fact that the missense
mutation studied here is likely to be a hypomorphic variant
(Fig. 5). Additionally, incomplete penetrance was evident in our
mouse models, with only 47% of mutants presenting with
elevated IOP at 4 months of age (Fig. 3C), which is consistent
with the observation that only 50% of patients with ARS develop
elevated IOP and glaucoma. Moreover, while teeth hypodontia or
microdontia is reported in some human ARS patients and not
others, no apparent non-ocular abnormalities were observed in
adult Pitx2KI mice. Thus, our mutants model recapitulates ocular
phenotypes of ARS patients with PITX2 mutations [16, 44, 45].
We demonstrate two possible pathological mechanisms that
underlie the glaucoma phenotypes induced by the missense
mutation in Pitx2 (Fig. 8). The observed anterior segment dysplasia
in Pitx2KI mice likely contributes to the dysfunction of the drainage
system leading to an elevation in IOP, which serves as an initiator of
the disease process. The mutation also exacerbates the high IOP-
induced oxidative stress in the retina by disrupting the interaction of
PITX2 with NRF2/YAP1, which consequently impairs the transcription
of several antioxidant genes. The reduction of antioxidant capacity
may accelerate RGC loss and optic neuropathy. The anterior
segment dysplasia caused by Pitx2 variation has been well
documented, but the precise mechanism through which subse-
quent pathogenesis occurs remains unclear. The present study
Fig. 6 Increased oxidative stress in the retinas of Pitx2KI mice. A–C Mean levels of SOD (A) and GSH-Px (B) activities, MDA (C) content in the
Pitx2WT (n= 13) and Pitx2KI (n= 11) retinas. Individual values are shown by dots in the histogram. D ROS activity measured by DHE staining; the
red staining is positive for ROS content. Nuclei were counter-stained with DAPI (blue). Scale bars: 200 μm. High-magnification images of boxed
areas are shown in the lower panel. Scale bars: 25 μm. E Quantification of the fluorescence intensity of DHE staining (n= 9). F Representative
confocal microscopy images of immunofluorescent staining of NRF2 (oxidative stress regulator, red) and DAPI (blue) in retina sections from 5-
week-old mice. Scale bar: 25 μm. G Representative immunoblots of 5-week-old retinal lysates from Pitx2WT and Pitx2KI mice stained for NRF2.
β-actin was used as the loading control. Uncropped immunoblotting images are shown in Fig. S12. H Quantification of immunoblots of retina
lysates from Pitx2WT and Pitx2KI mutant mice. NRF2 level (normalized to control) in retinas from mutant mice was elevated compared with
levels in control mice (n= 9). ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. *P < 0.05; **P < 0.01; ***P < 0.001. The
data are presented as mean ± SEM.
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mainly focuses on the latter, revealing a novel function of PITX2 in
RGCs and in glaucomatous pathogenesis. We demonstrated that
PITX2 moderates oxidative stress response through the NRF2-YAP1
axis in RGCs, whereas according to immunostaining data, this
mechanism does not appear to be involved in the early post-natal
phenotype (Fig. S11). The potential mechanisms triggering the
anterior segment dysgenesis warrant further investigation.
Owing to the high demand of oxygen and energy necessary to
generate action potentials, RGCs contain large number of
mitochondria throughout the cell soma, axon and dendrites
[46, 47]. Moreover, mitochondrial dysfunction has been recog-
nized to be relevant to the development of glaucoma [48–52].
Transcriptional analysis of DBA/2J glaucoma model revealed
mitochondrial dysfunction and metabolite depletion as a primary
cause of neuronal damage in glaucoma [53]. These studies
suggested that mitochondria dysfunction and oxidative stress play
important roles in glaucoma. In our Pitx2KI early-onset glaucoma
model, elevated expression levels of NRF2, a regulator of cellular
Y. Yang et al.
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resistance to oxidative stress, was observed (Fig. 6F–H). N-acetyl-L-
cysteine treatment mitigated RGC loss by inhibiting oxidative
stress in Pitx2mutant retinas (Figs. 7 and 8). Cumulatively, our data
identifies a potential target for development of therapeutic
strategies for ARS induced glaucoma and also, a potential strategy
for glaucoma therapy development.
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